Refine
Year of publication
- 2022 (237) (remove)
Document Type
- Doctoral Thesis (237) (remove)
Language
- English (134)
- German (101)
- Multiple languages (2)
Has Fulltext
- yes (237)
Is part of the Bibliography
- no (237)
Keywords
- ACLF (2)
- CBM (2)
- Digitalisierung (2)
- HADES (2)
- Leberzirrhose (2)
- Nierentransplantation (2)
- Saccharomyces cerevisiae (2)
- mTOR (2)
- 177Lu-PSMA (1)
- ACKR (1)
Institute
- Medizin (75)
- Biochemie, Chemie und Pharmazie (39)
- Biowissenschaften (32)
- Physik (25)
- Informatik und Mathematik (15)
- Geowissenschaften / Geographie (11)
- Neuere Philologien (8)
- Biochemie und Chemie (6)
- Psychologie und Sportwissenschaften (5)
- Gesellschaftswissenschaften (3)
Regulatory required, classical toxicity studies for environmental hazard assessment are costly, time consuming, and often lack mechanistic insights about the toxic mode of action induced through a compound. In addition, classical toxicological non-human animal tests raise serious ethical concerns and are not well suited for high throughput screening approaches. Molecular biomarker-based screenings could be a suitable alternative for identifying particular hazardous effects (e.g. endocrine disruption, developmental neurotoxicity) in non-target organisms at the molecular level. This, however, requires a better mechanistic understanding of different toxic modes of action (MoA) to describe characteristic molecular key events and respective markers.
Ecotoxicgenomics, which uses modern day omic technologies and systems biology approaches to study toxicological responses at the molecular level, are a promising new way for elucidating
the processes through which chemicals cause adverse effects in environmental organisms. In this context, this PhD study was designated to investigate and describe MoA-characteristic
ecotoxicogenomic signatures in three ecotoxicologically important aquatic model organisms of different trophic levels (Danio rerio, Daphnia magna and Lemna minor).
Applying non-target transcriptomic and proteomic methodologies post chemical exposure, the aim was to identify robust functional profiles and reliable biomarker candidates with potential
predictive properties to allow for a differentiation among different MoA in these organisms. For the sublethal exposure studies in the zebrafish embryo model (96 hpf), the acute fish embryo toxicity test guideline (OECD 236) was used as conceptual framework. As different test compounds with known MoA, the thyroid hormone 3,3′,5-triiodothyronine (T3) and the thyrostatic 6-propyl-2-thiouracil (6-PTU), as well as six nerve- and muscle-targeting insecticides (abamectin, carbaryl, chlorpyrifos, fipronil, imidacloprid and methoxychlor) were evaluated. Furthermore, a novel sublethal immune challenge assay in early zebrafish embryos (48 hpf) was evaluated for its potential to assess immuno-suppressive effects at the gene expression level. Therefore, toxicogenomic profiles after an immune response inducing stimulus with and without prior clobetasol propionate (CP) treatment were compared. For the aquatic invertebrate D. magna, the study was performed with previously determined low effect concentrations (EC5 & EC20) of fipronil and imidacloprid according to the acute immobilization test in water flea (OECD 202). The aim was to compare toxicogenomic signatures of the GABA-gated chloride channel blocker (fipronil) and the nAChR agonist (imidacloprid). With similar low effect concentrations, a shortened 3 day version of the growth inhibition test with L. minor (OECD 221) was conducted to find molecular profiles differentiating between photosynthesis and HMG-CoA reductase inhibitory effects. Here, the biological interpretation of the molecular stress response profiles in L. minor due to the lack of functional annotation of the reference genome was particularly challenging. Therefore, an annotation workflow was developed based on protein sequence homology predicted from the genomic reference sequences.
With this PhD work, it was shown how transcriptomic, proteomic and computational systems biology approaches can be coupled with aquatic toxicological tests, to gain important mechanistic insights into adverse effects at the molecular level. In general, for the different investigated adverse effects for the different organisms, biomarker candidates were identified, which describe a potential functional link between impaired gene expressions and previously reported apical effects. For the assessed chemicals in the zebrafish embryo model, biomarker candidates for thyroid disruption as well as developmental toxicity targeting the heart and central nervous system were described. The biomarkers derived from nerve- and muscletargeting insecticides were associated with three major affected processes: (1) cardiac muscle cell development and functioning, (2) oxygen transport and hypoxic stress and (3) neuronal development and plasticity. To our knowledge, this is the first study linking neurotoxic insecticide exposure and affected expression of important regulatory genes for heart muscle (tcap, actc2) and forebrain (npas4a) development in a vertebrate model. The proposed immunosuppression assay found CP to affect innate immune induction by attenuating the response of genes involved in antigen processing, TLR signalling, NF-КB signalling, and complement activation ...
As one of the most widespread infectious diseases in the world, it is currently estimated that approximately 296 million people globally are chronically infected with Hepatitis B virus (HBV), the consequences of HBV infection cause more than 620,000 deaths each year. Although safe and effective HBV vaccines have reduced the incidence of new HBV infections in most countries, there are still around 1.5 million new infections each year. HBV remains a major health problem because there is no large-scale effective vaccination strategy in many countries with a high burden of disease, many people with chronic HBV infection are not receiving effective and timely treatment, and a complete cure for chronic infection is still far from being achieved.
Since its discovery, HBV has been identified as an enveloped DNA virus with a diameter of 42 nm. For efficient egress from host cells, HBV is thought to acquire the viral envelope by budding into multivesicular bodies (MVBs) and escape from infected cells via the exosome release pathway. It is clear that HBV hijacks the host vesicle system to complete self-assembly and propagation by interacting with factors that mediate exosome formation. Consequently, the overlap with exosome biogenesis, using MVBs as the release platform, raises the possibility for the release of exosomal HBV particles. Currently, virus containing exosomal vesicles have been described for several viruses. In light of this, this study explored whether intact HBV-virions wrapped in exosomes are released by HBV-producing cells.
First, this study established a robust method for efficient separation of exosomes from HBV virions by a combination of differential ultracentrifugation and iodixanol density gradient centrifugation. Fractionation of the density gradient revealed that two populations of infectious viral particles can be separated from the culture fluids of HBV-producing cells. The population present in the low-density peak co-migrates with the exosome markers. Whereas the population that appeared in the high-density fractions was the classical HBV virions, which are rcDNA-containing nucleocapsids encapsulated by the HBV envelope.
Subsequently, the characterization of this low-density population was performed, namely the highly purified exosome fraction was systematically investigated. Relying on the detergent sensitivity of the exosome membrane and the outer envelope of the HBV virus, disruption of the exosome structure by treatment with limited detergent revealed the presence of HBsAg in the exosomes. At the same time, mild and limited NP-40 treatment of highly purified exosomes and a further combination of density gradient centrifugation resulted in the stepwise release of intact HBV virions and naked capsids from the exosomes generated by HBV-producing cells. This implies the presence of intact HBV particles encapsulated by the host membrane.
The presence of exosome-encapsulated HBV particles was consequently also verified by suppressing the morphogenesis of MVBs or exosomes. Impairment of MVB- or exosome-generation with small molecule inhibitors has significantly inhibited the release of host membrane-encapsulated HBV particles as well. Likewise, silencing of exosome-related proteins caused a diminution of exosome output, which compromised the budding efficiency of wrapped HBV.
Moreover, electron microscopy images of ultra-thin sections combined with immunogold staining visualized the hidden virus in the exosomal structure. Additionally, the presence of LHBs on the surface of exosomes derived from HBV-expressing cells was also observed.
As expected, these exosomal membrane-wrapped HBV particles can spread productive infection in differentiated HepaRG cells. In HBV-susceptible cells, as LHBs on the membrane surface, this type of exosomal HBV appeared to be uptaken in an NTCP receptor-dependent manner.
Taken together these data indicate that a fraction of intact HBV virions can be released as exosomes. This reveals a so far not described release pathway for HBV. Exosomes hijacked by HBV act as a transporter impacting the dissemination of the virus.
Ischemic heart disease caused by occlusion of coronary vessels leads to the death of downstream tissues, resulting in a fibrotic scar that cannot be resolved. In contrast to the adult mammalian heart, the adult zebrafish heart can regenerate following injury, enabling the study of the underlying cellular and molecular mechanisms. One of the earliest responses that take place after cardiac injury in adult zebrafish is coronary revascularization. Previous transcriptomic data from our lab show that vegfc, a well-known regulator of lymphatic development, is upregulated early after injury and peaks at 96 hours post cryoinjury, coinciding with the peak of coronary endothelial cell proliferation. To test the hypothesis that vegfc is involved in coronary revascularization, I examined its expression pattern and found that it is expressed by coronary endothelial cells after cardiac damage. Using a loss-of-function approach to block Vegfc signaling, I found that it is required for coronary revascularization during cardiac regeneration. Notably, blocking Vegfc signaling resulted in a significant reduction in cardiomyocyte regeneration. Using transcriptomic analysis, I identified the extracellular matrix component gene emilin2a and the chemokine gene cxcl8a as effectors of Vegfc signaling. During cardiac regeneration, cxcl8a is expressed in epicardium-derived cells, while the gene encoding its receptor cxcr1 is expressed on coronary endothelial cells. I found that overexpressing emilin2a increases coronary revascularization, and induces cxcl8a expression. Using loss-of-function approaches, I observed that both cxcl8a and cxcr1 are required for coronary revascularization after cardiac injury.
Altogether, my findings indicate that Vegfc acts as an angiocrine factor that plays an important role in regulating cardiac regeneration in zebrafish. Mechanistically, Vegfc promotes the expression of emilin2a, which promotes coronary proliferation, at least in part by enhancing Cxcl8a-Cxcr1 signaling. This study helps in understanding the mechanisms underlying coronary revascularization during cardiac regeneration, with promising therapeutic applications for human heart regeneration.
Generally speaking, protein import into mitochondria and chloroplasts is a post-translational process during which the precursor proteins destined for mitochondria or chloroplasts are translated with cytosolic ribosomes and targeted. The previous results showed that the isolated chloroplasts can import in vitro synthesized proteins and the absence of ribosomes in the immediate area around chloroplasts in electron microscopy (EM) images. However, none of the EM images were recorded in the presence of a translation elongation inhibitor. Also, the observation showed that ribosomes stably bind to purified liver mitochondria in vitro, and the first indication of chloroplast localization of mRNAs encoding plastid proteins in Chlamydomonas rheinhardtii, which challenge the post-translational import and support the co-translational process. Therefore, in this study, the association of the ribosomes to the isolated chloroplasts were analyzed, a binding assay was established and showed that naked ribosomes are not considerably bound to chloroplasts. Additionally, mRNA localize in close vicinity to mitochondria also challenged post-translation protein import. Global analysis of transcripts bound to mitochondria in yeast or human revealed that around half of the transcripts of mitochondrial proteins displayed a high mitochondrial localization. The observed association of mRNAs with chloroplast fractions and the in vivo analysis of the distribution of mRNAs was used as base to formulate the hypothesis that mRNA can bind to chloroplast surface. Therefore, in this study, the mRNA binding assay was established and revealed that mRNAs coding for the mitochondrial cytochrome c oxidase copper chaperone COX17 showed unspecific binding to the chloroplasts. The mRNA coding for chloroplast outer envelope transport protein OEP24 and mRNA coding for the essential nuclear protein 1 (ENP1) showed specific binding, and OEP24 has a 3-fold higher affinity than ENP1 mRNA. Moreover, the BY2-L (Nicotiana tabacum non-green cell culture) could confer the highest enhancement of OEP24 mRNA binding efficiency than the COX17 and ENP1 mRNA and the preparation of the BY2-L was optimized. Afterwards, the feasibility to fix the interaction between mRNA and the proteins on the surface of chloroplasts was confirmed. OEP24 mRNA showed more efficiency in the UV-crosslinking. Following, the pull-down with antisense locked nucleic acid (LNA)/DNA oligonucleotides was established which could be used for the further investigation of the proteins involved in the mRNA binding to the chloroplasts.
With 5-10 newly diagnosed patients per 100,000 people every year, glioblastoma is the most common malignant primary brain tumor. Despite extensive research activity in the last decades, clinical effectiveness of the currently available therapy standard of surgery, radiochemotherapy and tumor-treating fields is still limited and mean survival rates in unselected collectives are only about one year. Accordingly, there is an urgent need to explore new therapeutic options. The current standard of care includes surgery followed by radiation therapy in combination with the alkylating chemotherapeutic agent Temozolomide. Even with successful initial therapy, tumor recurrence is still inevitable. Currently, there are no defined recommendations for clinical management of the disease in the event of tumor recurrence. Only 20-30% of patients qualify for a second surgical resection, while other options include retreatment with Temozolomide, CCNU (Lomustine) or Regorafenib and enrollment in a clinical trial.
The development of immunotherapies for glioblastoma, in particular, has been the focus of intense preclinical and clinical efforts. However, low numbers of mutations and a highly immunosuppressive tumor microenvironment result in glioblastoma being considered an immunologically “cold” tumor. Strategies successfully established in mutagen-induced tumors with antibodies directed against the PD-1, PD-L1 or CTLA-A4 immune checkpoints have therefore failed in glioblastoma.
Cellular immunotherapies based on chimeric antigen receptor (CAR)-technology have emerged as an alternative powerful option to tackle immunologically “cold” tumors. Several CAR-T cell products targeting glioma antigens have been developed and some evidence of clinical activity has been demonstrated. Natural killer (NK) cells as carriers of CAR constructs have several advantages over T cells, including a much lower risk of neurotoxicity and better interaction with immune cells in the microenvironment. Based on the human NK cell line NK-92, a clinical-grade product, suitable as an off-the-shelf therapeutic, has been developed. The NK-92/5.28.z clone (CAR-NK) expresses a CAR based on the HER2-specific antibody FRP5 in addition to signal-enhancing CD28 and CD3ζ domains. Similar to several other tumor entities, overexpression of the growth factor receptor HER2 is often found in glioblastoma patients. Because of its substantial role in the regulation of cell proliferation, survival, differentiation, angiogenesis and invasion, this receptor is classified as an oncogene. HER2 overexpression plays a major role in the malignant transformation of cells and its oncogenic potential has been studied in detail in breast cancer. However, HER2 expression was also found in up to 80% of glioblastomas, which correlates with an impaired probability of survival. Under physiological conditions, HER2 is not expressed in the adult central nervous system, making it a promising target antigen for glioblastoma immunotherapy.
In previous projects, it has already been shown that these CAR-NK cells exhibit a high and specific lytic activity towards HER2+ glioblastoma cells. While repetitive intratumoral injections of CAR-NK cells already significantly extended symptom-free survival in murine orthotopic xenograft models, CAR-NK cell therapy in immunocompetent mice promotes an endogenous anti-tumor immune response which improves tumor control and provides persisting anti-tumor immunity after therapy of early-stage tumors. However, in more advanced tumor models, efficacy is limited and induction of the checkpoint-molecule PD-L1 in response to CAR-NK-cell therapy was identified as a key mechanism of therapy resistance.
Immunotherapy employing the intravenous administration of checkpoint inhibitors has already revolutionized the treatment of various malignant diseases such as melanoma or lung cancer. In particular, the approach of cancer immunotherapy has focused on the systemic administration of antibodies directed against immune checkpoints such as PD-1, PD-L1 and CTLA-4. In glioblastoma, both tumor cells and microglia, the brain-resident macrophages, express PD-L1, which hinders the activation of CD8+ and CD4+ T cells. Therefore, immunotherapy directed against the PD-1/PD-L1 axis represents a promising approach for the treatment of glioblastoma. One problem, however, is the severe toxicity caused by the systemic effects of checkpoint inhibitors, since the immune response is stimulated not only in tumor tissue but also in healthy organs. Serious side effects such as colitis, hepatitis, pancreatitis or hypophysitis, including numerous deaths, have been reported.
This study aimed to improve the efficacy of CAR-NK cell therapy by combining it with adeno-associated virus (AAV)-mediated transfer of anti-PD-1 antibodies as a strategy to enable local combination therapy to control intracranial tumors.
AAVs carrying a payload coding for an anti-PD-1 immunoadhesin (aPD-1) retargeted to HER2-expressing cells by fusion of so-called Designed Ankyrin Repeat Proteins (DARPins) with a viral capsid protein were employed for this to focus checkpoint inhibitor therapy to the tumor area, resulting in high intratumoral and low systemic drug concentrations. ...
Sensors for high rate charge particle tracking have to withstand the harsh radiation doses deposited by the particles to be sensed. This holds particularly for the novel CMOS Monolithic Active Pixel Sensors, which are considered a promising sensor technology for future vertex detectors due to their very light material budget and excellent spatial resolution. To resist the radiation doses expected close to the interaction regions of heavy-ion experiments, the sensors have to be hardened against radiation doses, which exceed the native tolerance of CMOS technology significantly. In this thesis, the results of non-ionizing radiation hardness studies at the IKF on sensor prototypes developed at the IPHC in Strasbourg are presented. Our results demonstrate that the CMOS sensors evaluated in the context of this thesis can withstand non-ionizing radiation of up to 5×10^14 neq/cm^2. This hardness qualifies them as promising candidates for use in future vertex detectors.
The stellar nucleosynthesis of elements heavier than iron can primarily be attributed to neutron capture reactions in the s and r process. While the s process is considered to be well understood with regards to the stellar sites, phases and conditions where it occurs, nucleosynthesis networks still need accurate neutron capture cross sections
with low uncertainties as input parameters. Their quantitative outputs for the isotopic abundances produced in the s process, coupled with the observable solar abundances, can be used to indirectly infer the expected r process abundances. The two stable gallium isotopes, 69Ga and 71Ga, have been shown in sensitivity studies to have considerable impact on the weak s process in massive stars. The available experimental data, mostly derived from neutron activation measurements for quasi-stellar neutron spectra at kBT = 25 keV, show disagreements up to a factor of three.
Determining the differential neutron capture cross section can provide input data for the whole range of astrophysically relevant energies. To that end, a neutron time of flight experimental campaign at the n_TOF facility at CERN was performed for three months, using isotopically enriched samples of both isotopes. The data taken at the EAR1 experimental area covered a wide neutron energy range from thermal to several hundred keV. The respective differential and spectrum averaged neutron capture cross sections for 69Ga and 71Ga were determined in this thesis. They show good agreement with the evaluated cross sections for 71Ga, but reproduce the deviations from the evaluated data that other, more recent activation measurements showed for 69Ga.
The main task of modern large experiments with heavy ions, such as CBM (FAIR), STAR (BNL) and ALICE (CERN) is a detailed study of the phase diagram of quantum chromodynamics (QCD) in the quark-gluon plasma (QGP), the equation of state of matter at extremely high baryonic densities, and the transition from the hadronic phase of matter to the quark-gluon phase.
In the thesis, the missing mass method is developed for the reconstruction of short-lived particles with neutral particles in their decay products, as well as its implementation in the form of fast algorithms and a set of software for prac- tical application in heavy ion physics experiments. Mathematical procedures implementing the method were developed and implemented within the KF Par- ticle Finder package for the future CBM (FAIR) experiment and subsequently adapted and applied for processing and analysis of real data in the STAR (BNL) experiment.
The KF Particle Finder package is designed to reconstruct most signal particles from the physics program of the CBM experiment, including strange particles, strange resonances, hypernuclei, light vector mesons, charm particles and char- monium. The package includes searches for over a hundred decays of short-lived particles. This makes the KF Particle Finder a universal platform for short-lived particle reconstruction and physics analysis both online and offline.
The missing mass method has been proposed to reconstruct decays of short-lived charged particles when one of the daughter particles is neutral and is not regis- tered in the detector system. The implementation of the missing mass method was integrated into the KF Particle Finder package to search for 18 decays with a neutral daughter particle.
Like all other algorithms of the KF Particle Finder package, the missing mass method is implemented with extensive use of vector (SIMD) instructions and is optimized for parallel operation on modern many-core high performance com- puter clusters, which can include both processors and coprocessors. A set of algorithms implementing the method was tested on computers with tens of cores and showed high speed and practically linear scalability with respect to the num- ber of cores involved.
It is extremely important, especially for the initial stage of the CBM experiment, which is planned for 2025, to demonstrate already now on real data the reliability of the developed approach, as well as the high efficiency of the current implemen- tation of both the entire KF Particle Finder package, and its integral part, the missing mass method. Such an opportunity was provided by the FAIR Phase-0 program, motivating the use in the STAR experiment of software packages orig- inally developed for the CBM experiment.
Application of the method to real data of the STAR experiment shows very good results with a high signal-to-background ratio and a large significance value. The results demonstrate the reliability and high efficiency of the missing mass method in the reconstruction of both charged mother particles and their neutral daughter particles. Being an integral part of the KF Particle Finder package, now the main approach for reconstruction and analysis of short-lived particles in the STAR experiment, the missing mass method will continue to be used for the physics analysis in online and offline modes.
The high quality of the results of the express data analysis has led to their status as preliminary physics results with the right to present them at international physics conferences and meetings on behalf of the STAR Collaboration.
Die Entstehung der Elemente im Universum wird auf eine Vielzahl von Prozessen zurückgeführt, die sowohl in Urknall - als auch in stellaren Szenarien angesiedelt werden. Die Kenntnis der dort ablaufenden Reaktionen und deren Raten ermöglicht es die zugrundeliegenden Modelle einzugrenzen und somit genauere Aussagen über die Plausibilität der Szenarien zu treffen. Ein Teil dieser Prozesse stützt sich auf Neutroneneinfänge an Atomkernen, wodurch die Massezahl des Ausgangskerns erhöht wird.
Die Aktivierungsmethode ermöglicht die Bestimmung der Wahrscheinlichkeit eines Neutroneneinfangs, sofern der Zielkern eine detektierbare Radioaktivität aufweist. Die experimentelle Untersuchung einer Reaktion mit einem kurzlebigen Produktkern ist eine besondere Herausforderung, da bei langen Aktivierungen zwar viele Einfänge stattfinden, die meisten Produktkerne jedoch schon während der Aktivierung zerfallen. Ein probates Mittel um genügend Zerfälle des Produktkerns beobachten zu können ist die zyklische Aktivierung, wobei die Probe in mehrfachen Wiederholungen kurz bestrahlt und ausgezählt wird.
Im Rahmen dieser Arbeit wurden zwei verschiedene Anwendungen der zyklischen Aktivierung behandelt.
Eine vom Paul Scherrer Institut Villigen bereitgestellte Probe von 10Be wurde am TRIGA Reaktor der Johannes Gutenberg - Universität Mainz mit Neutronen aktiviert. Über die Cadmiumdifferenzmethode konnte der thermische und der epithermische Anteil der Neutronen separiert werden und dadurch sowohl der thermische Wirkungsquerschnitt als auch das Resonanzintegral für die Reaktion 10Be(n,γ)11Be bestimmt werden.
Am Institut für Kernphysik der Goethe Universität Frankfurt wurde mit einem Van - de - Graaff - Beschleuniger über die 7Li(p,n)7Be Reaktion ein quasistellares Neutronenspektrum mit kBT ≈ 25 keV erzeugt. Für die zyklische Aktivierung von Proben wurde die Infrastruktur in Form einer automatisiert ablaufenden Vorrichtung zur Bestrahlung und Auszählung geplant und umgesetzt. In diesem Rahmen wurden die über das Spektrum gemittelten Neutroneneinfangsquerschnitte für verschiedene Reaktionen bestimmt. Für 19F(n,γ)20F konnte der Gesamteinfangsquerschnitt bestimmt werden. Für die Reaktion 45Sc(n,γ)46Sc wurde der partielle Wirkungsquerschnitt in den 142,5 keV Isomerzustand gemessen. Aus der 115In(n,γ)116In Reaktion konnten die partiellen Querschnitte in die Isomerzustände bei 289,7 keV, 127,3 keV sowie den Grundzustand bestimmt werden.
Außerdem wurde mit einer Hafniumprobe die partiellen Einfangsquerschnitte in den 1147,4 keV Isomerzustand von 178Hf und in den 375 keV Isomerzustand von 179Hf gemessen.
Ziel der vorliegenden Arbeit war die Untersuchung der Kurzzeitdynamik zirkulierender Tumorzellen bei hepatozellulären Karzinompatienten, die erstmalig eine radiologische Intervention in Form einer transarteriellen Chemoembolisation oder einer Mikrowellenablation als Therapie erhielten. Dafür wurde in Vorversuchen eine neuartige Methode zur Isolation und Detektion von zirkulierenden Tumorzellen entwickelt.
Zugleich sollte ein potenzieller Einsatz dieser Methode als Screeningverfahren für hepatozelluläre Karzinompatienten mithilfe der Sensitivität und Spezifität überprüft werden. Darüber hinaus wurde eine mögliche Korrelation der Kurzzeitdynamik zirkulierender Tumorzellen sowohl mit der Kurzzeitdynamik des AFP-Wertes als anerkannten HCC-Tumormarker, als auch des IL-6-Wertes als aktuell diskutierten Tumormarker analysiert. Ferner wurde die Kurzzeitdynamik zirkulierender Tumorzellen mit dem klinischen Verlauf der Patienten verglichen.
Im Zeitraum von September 2017 bis Juni 2018 konnten Blutproben von 18 Patienten mit einem hepatozellulären Karzinom untersucht werden. Davon wurden zehn Patienten mittels Mikrowellenablation und acht Patienten mittels transarterieller Chemoembolisation behandelt. Daneben wurden Blutproben von 13 gesunden Probanden ausgewertet.
Methodisch wurden jeweils im Anschluss an die Gewinnung des Patientenblutes, vor und unmittelbar nach jeweiliger radiologischer Intervention, die zirkulierenden Tumorzellen aus dem Blut isoliert und die gewonnenen Zellen durch die Durchflusszytometrie nachgewiesen und quantifiziert. Als zirkulierende Tumorzellen wurden dabei jene Zellen betrachtet, die eine Negativität auf den Marker CD45 sowie eine Positivität auf die Marker ASGPR-1, CD146, CD274 und CD90 zeigten.
Durch den Vergleich der Proben vor und nach radiologischer Intervention konnte gezeigt werden, dass die Anzahlen zirkulierender Tumorzellen nach der radiologischen Intervention im Mittel niedriger sind als vor der Therapie. Die Anzahl zirkulierender Tumorzellen sank dabei im Schnitt bei den mit Mikrowellenablation behandelten Patienten stärker im Vergleich zu denen, die eine transarterielle Chemoembolisation erhielten. Dies bestätigte den klinischen Verlauf der Patientengruppen, da die Mortalität der Gruppe, die eine transarterielle Chemoembolisation erhielten deutlich höher war als bei den übrigen Patienten.
Als klinisch einsetzbare Screening-Methode im Sinne einer „Liquid Biopsy“ für das HCC müssen die Sensitivität und Spezifität weitergehend optimiert werden. Eine signifikante Korrelation zwischen der Kurzzeitdynamik der Anzahlen zirkulierender Tumorzellen und der Kurzzeitdynamik der AFP-Werte und der IL-6-Werte konnte nicht festgestellt werden. Entgegen des erwarteten Trends, legte die angewendete Methode, durch das Absinken der zirkulierenden Tumorzellen, die positive Wirkung der transarteriellen Chemoembolisation und der Mikrowellenablation in hepatozellulären Karzinompatienten dar.